You are here

Home

Biblio

Journal Article
Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, Pase MP, Himali JJ, B Windham G, Griswold M et al..  2020.  Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies.. Lancet Neurol. 19(1):61-70.
Rajabli F, Feliciano BE, Celis K, Hamilton-Nelson KL, Whitehead PL, Adams LD, Bussies PL, Manrique CP, Rodriguez A, Rodriguez V et al..  2018.  Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.. PLoS Genet. 14(12):e1007791.
Ma Y, Jun GR, Zhang X, Chung J, Naj AC, Chen Y, Bellenguez C, Hamilton-Nelson K, Martin ER, Kunkle BW et al..  2019.  Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype.. JAMA Neurol.
Nafikov RA, Nato AQ, Sohi H, Wang B, Brown L, Horimoto AR, Vardarajan BN, Barral SM, Tosto G, Mayeux RP et al..  2018.  Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP.. Genet Epidemiol. 42(6):500-515.
Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al..  2017.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.
Lancour D, Dupuis J, Mayeux R, Haines JL, Pericak-Vance MA, Schellenberg GC, Crovella M, Farrer LA, Kasif S.  2020.  Analysis of brain region-specific co-expression networks reveals clustering of established and novel genes associated with Alzheimer disease.. Alzheimers Res Ther. 12(1):103.
Deters KD, Napolioni V, Sperling RA, Greicius MD, Mayeux R, Hohman T, Mormino EC.  2021.  Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.. Neurology. 96(11):e1491-e1500.
Beecham GW, Bis JC, Martin ER, Choi S-H, DeStefano AL, van Duijn CM, Fornage M, Gabriel SB, Koboldt DC, Larson DE et al..  2017.  The Alzheimer's Disease Sequencing Project: Study design and sample selection.. Neurol Genet. 3(5):e194.
Crane PK, Foroud T, Montine TJ, Larson EB.  2017.  Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.. Alzheimers Dement. 13(12):1410-1413.
Chaudhury S, Brookes KJ, Patel T, Fallows A, Guetta-Baranes T, Turton JC, Guerreiro R, Bras J, Hardy J, Francis PT et al..  2019.  Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment.. Transl Psychiatry. 9(1):154.
Braggin JE, Bucks SA, Course MM, Smith CL, Sopher B, Osnis L, Shuey KD, Domoto-Reilly K, Caso C, Kinoshita C et al..  2019.  Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.. Ann Clin Transl Neurol. 6(4):762-777.
Horimoto ARVR, Xue D, Thornton TA, Blue EE.  2021.  Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics.. Alzheimers Res Ther. 13(1):122.
Spartano NL, Demissie S, Himali JJ, Dukes KA, Murabito JM, Vasan RS, Beiser AS, Seshadri S.  2019.  Accelerometer-determined physical activity and cognitive function in middle-aged and older adults from two generations of the Framingham Heart Study.. Alzheimers Dement (N Y). 5:618-626.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer